N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide

C82H91N23O4S2 — CID 158899472

IUPACN-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide
SMILESC=CC(=O)Nc1cccc(Oc2nc(Nc3nc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1.C=CC(=O)Nc1cccc(Sc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1.C=CC(=O)Nc1cccc(Sc2nc(Nc3nc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1
InChIInChI=1S/C28H31N7OS.C27H30N8O2.C27H30N8OS/c1-5-26(36)30-21-7-6-8-22(17-21)37-28-33-27(32-25-9-12-29-35(25)28)31-24-16-18(2)23(15-19(24)3)20-10-13-34(4)14-11-20;2*1-5-24(36)30-20-7-6-8-21(16-20)37-27-33-26(31-23-9-12-28-35(23)27)32-25-17(2)15-22(18(3)29-25)19-10-13-34(4)14-11-19/h5-9,12,15-17,20H,1,10-11,13-14H2,2-4H3,(H,30,36)(H,31,32);2*5-9,12,15-16,19H,1,10-11,13-14H2,2-4H3,(H,30,36)(H,29,31,32)
InChIKeyJFGFDKLNYMRQFY-UHFFFAOYSA-N
MW1526.92 g/mol
LogP15.14
Rot. Bonds21

About N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide

N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide (PubChem CID 158899472) has the molecular formula C82H91N23O4S2 and a molecular weight of 1526.92 g/mol. Its IUPAC name is N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide.

Molecular Properties

Compound NameN-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide
PubChem CID158899472
Molecular FormulaC82H91N23O4S2
Molecular Weight1526.92 g/mol
Exact Mass1525.71
IUPAC NameN-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide
SMILESC=CC(=O)Nc1cccc(Oc2nc(Nc3nc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1.C=CC(=O)Nc1cccc(Sc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1.C=CC(=O)Nc1cccc(Sc2nc(Nc3nc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1
InChIInChI=1S/C28H31N7OS.C27H30N8O2.C27H30N8OS/c1-5-26(36)30-21-7-6-8-22(17-21)37-28-33-27(32-25-9-12-29-35(25)28)31-24-16-18(2)23(15-19(24)3)20-10-13-34(4)14-11-20;2*1-5-24(36)30-20-7-6-8-21(16-20)37-27-33-26(31-23-9-12-28-35(23)27)32-25-17(2)15-22(18(3)29-25)19-10-13-34(4)14-11-19/h5-9,12,15-17,20H,1,10-11,13-14H2,2-4H3,(H,30,36)(H,31,32);2*5-9,12,15-16,19H,1,10-11,13-14H2,2-4H3,(H,30,36)(H,29,31,32)
InChIKeyJFGFDKLNYMRQFY-UHFFFAOYSA-N
XLogP15.14
TPSA297.36 Ų
H-Bond Donors6
H-Bond Acceptors26
Rotatable Bonds21
Heavy Atoms111
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001526.92
LogP ≤ 515.14
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide?
The IUPAC name of N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide (CID 158899472) is N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide.
What is the SMILES notation for N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide?
The canonical SMILES for N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide is C=CC(=O)Nc1cccc(Oc2nc(Nc3nc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1.C=CC(=O)Nc1cccc(Sc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1.C=CC(=O)Nc1cccc(Sc2nc(Nc3nc(C)c(C4CCN(C)CC4)cc3C)nc3ccnn23)c1.
What is the InChIKey of N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide?
The InChIKey is JFGFDKLNYMRQFY-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H31N7OS.C27H30N8O2.C27H30N8OS/c1-5-26(36)30-21-7-6-8-22(17-21)37-28-33-27(32-25-9-12-29-35(25)28)31-24-16-18(2)23(15-19(24)3)20-10-13-34(4)14-11-20;2*1-5-24(36)30-20-7-6-8-21(16-20)37-27-33-26(31-23-9-12-28-35(23)27)32-25-17(2)15-22(18(3)29-25)19-10-13-34(4)14-11-19/h5-9,12,15-17,20H,1,10-11,13-14H2,2-4H3,(H,30,36)(H,31,32);2*5-9,12,15-16,19H,1,10-11,13-14H2,2-4H3,(H,30,36)(H,29,31,32).
What are the key properties of N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide?
N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide has a molecular weight of 1526.92 g/mol, XLogP of 15.14, 21 rotatable bonds, 6 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[2-[2,5-dimethyl-4-(1-methylpiperidin-4-yl)anilino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[2-[[3,6-dimethyl-5-(1-methylpiperidin-4-yl)-2-pyridinyl]amino]pyrazolo[1,5-a][1,3,5]triazin-4-yl]sulfanylphenyl]prop-2-enamide is sourced from PubChem (CID 158899472), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).